E. Antonio Chiocca

6.1k total citations · 1 hit paper
81 papers, 4.7k citations indexed

About

E. Antonio Chiocca is a scholar working on Molecular Biology, Genetics and Epidemiology. According to data from OpenAlex, E. Antonio Chiocca has authored 81 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 45 papers in Genetics and 20 papers in Epidemiology. Recurrent topics in E. Antonio Chiocca's work include Virus-based gene therapy research (45 papers), RNA Interference and Gene Delivery (17 papers) and Viral Infectious Diseases and Gene Expression in Insects (17 papers). E. Antonio Chiocca is often cited by papers focused on Virus-based gene therapy research (45 papers), RNA Interference and Gene Delivery (17 papers) and Viral Infectious Diseases and Gene Expression in Insects (17 papers). E. Antonio Chiocca collaborates with scholars based in United States, Germany and China. E. Antonio Chiocca's co-authors include Samuel D. Rabkin, Ralph Weissleder, James P. Basilion, Peter J. Davies, Helene Benveniste, Umar Mahmood, Anna Moore, Manish K. Aghi, Jason Stein and Sean Lawler and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

E. Antonio Chiocca

77 papers receiving 4.6k citations

Hit Papers

In vivo magnetic resonance imaging of transgene expression 2000 2026 2008 2017 2000 200 400 600

Peers

E. Antonio Chiocca
Ilya V. Ulasov United States
Vimla Band United States
Anna Jauch Germany
Ernest S. Kawasaki United States
Long‐Sheng Chang United States
Linda Rangell United States
E. Antonio Chiocca
Citations per year, relative to E. Antonio Chiocca E. Antonio Chiocca (= 1×) peers Selvarangan Ponnazhagan

Countries citing papers authored by E. Antonio Chiocca

Since Specialization
Citations

This map shows the geographic impact of E. Antonio Chiocca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Antonio Chiocca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Antonio Chiocca more than expected).

Fields of papers citing papers by E. Antonio Chiocca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Antonio Chiocca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Antonio Chiocca. The network helps show where E. Antonio Chiocca may publish in the future.

Co-authorship network of co-authors of E. Antonio Chiocca

This figure shows the co-authorship network connecting the top 25 collaborators of E. Antonio Chiocca. A scholar is included among the top collaborators of E. Antonio Chiocca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Antonio Chiocca. E. Antonio Chiocca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zdioruk, Mykola, Michal O. Nowicki, Katherine E. Manz, et al.. (2023). PPRX-1701, a nanoparticle formulation of 6′-bromoindirubin acetoxime, improves delivery and shows efficacy in preclinical GBM models. Cell Reports Medicine. 4(5). 101019–101019. 8 indexed citations
2.
Koch, Marilin, Mykola Zdioruk, Michal O. Nowicki, et al.. (2022). Perturbing DDR signaling enhances cytotoxic effects of local oncolytic virotherapy and modulates the immune environment in glioma. Molecular Therapy — Oncolytics. 26. 275–288. 6 indexed citations
3.
Godlewski, Jakub, Franz Ricklefs, Carmela Passaro, et al.. (2021). Oncolytic Virus Therapy Alters the Secretome of Targeted Glioblastoma Cells. Cancers. 13(6). 1287–1287. 11 indexed citations
4.
Jackson, Joseph W., Bonnie L. Hall, Lisa Bailey, et al.. (2021). Treatment of glioblastoma with current oHSV variants reveals differences in efficacy and immune cell recruitment. Molecular Therapy — Oncolytics. 22. 444–453. 7 indexed citations
5.
Han, Jianfeng, Xilin Chen, Jianhong Chu, et al.. (2015). TGFβ Treatment Enhances Glioblastoma Virotherapy by Inhibiting the Innate Immune Response. Cancer Research. 75(24). 5273–5282. 74 indexed citations
6.
Freeman, Gordon J., Catherine J. Wu, E. Antonio Chiocca, et al.. (2014). Immunotherapy advances for glioblastoma. Neuro-Oncology. 16(11). 1441–1458. 146 indexed citations
7.
Yoo, Ji Young, Jason Pradarelli, Amy Haseley, et al.. (2012). Copper Chelation Enhances Antitumor Efficacy and Systemic Delivery of Oncolytic HSV. Clinical Cancer Research. 18(18). 4931–4941. 34 indexed citations
8.
Gatson, Na Tosha, E. Antonio Chiocca, & Balveen Kaur. (2012). Anti-angiogenic gene therapy in the treatment of malignant gliomas. Neuroscience Letters. 527(2). 62–70. 43 indexed citations
9.
Dmitrieva, Nina, Lianbo Yu, Mariano S. Viapiano, et al.. (2010). Chondroitinase ABC I–Mediated Enhancement of Oncolytic Virus Spread and Antitumor Efficacy. Clinical Cancer Research. 17(6). 1362–1372. 70 indexed citations
10.
Elsheikh, Bakri, John T. Kissel, Gregory A. Christoforidis, et al.. (2009). Spinal angiography and epidural venography in juvenile muscular atrophy of the distal arm “Hirayama disease”. Muscle & Nerve. 40(2). 206–212. 24 indexed citations
11.
Chang, Susan M., Michael A. Vogelbaum, Frederick F. Lang, et al.. (2006). GNOSIS: Guidelines for Neuro-Oncology: Standards for Investigational Studies — reporting of surgically based therapeutic clinical trials. Journal of Neuro-Oncology. 82(2). 211–220. 12 indexed citations
12.
Wakimoto, Hiroaki, Giulia Fulci, Edyta Tyminski, & E. Antonio Chiocca. (2004). Altered expression of antiviral cytokine mRNAs associated with cyclophosphamide's enhancement of viral oncolysis. Gene Therapy. 11(2). 214–223. 95 indexed citations
13.
Nakamura, Hideo, Hideki Kasuya, John T. Mullen, et al.. (2002). Regulation of herpes simplex virus γ134.5 expression and oncolysis of diffuse liver metastases by Myb34.5. Journal of Clinical Investigation. 109(7). 871–882. 39 indexed citations
14.
Weissleder, Ralph, Anna Moore, Umar Mahmood, et al.. (2000). In vivo magnetic resonance imaging of transgene expression. Nature Medicine. 6(3). 351–354. 624 indexed citations breakdown →
15.
Neuwelt, Edward A., N. Joan Abbott, Lester R. Drewes, et al.. (1999). Cerebrovascular Biology and the Various Neural Barriers: Challenges and Future Directions. Neurosurgery. 44(3). 604–608. 34 indexed citations
16.
Neuwelt, Edward A., N. Joan Abbott, Lester R. Drewes, et al.. (1999). Cerebrovascular biology and the various neural barriers. Neurosurgery. 44(3).
17.
Rainov, Nikolai G., Keiro Ikeda, Ulrich Herrlinger, et al.. (1999). Intraarterial Delivery of Adenovirus Vectors and Liposome-DNA Complexes to Experimental Brain Neoplasms. Human Gene Therapy. 10(2). 311–318. 43 indexed citations
18.
Rainov, Nikolai G., et al.. (1998). A Chimeric Fusion Protein of Cytochrome CYP4B1 and Green Fluorescent Protein for Detection of Pro-Drug Activating Gene Delivery and for Gene Therapy in Malignant Glioma. Advances in experimental medicine and biology. 451. 393–403. 22 indexed citations
19.
Tang, Gordon Y. N. & E. Antonio Chiocca. (1997). Gene transfer and delivery in central nervous system disease. Neurosurgical FOCUS. 3(3). E4–E4. 1 indexed citations
20.
Boviatsis, Efstathios, Maureen Chase, Ming Wei, et al.. (1994). Gene Transfer into Experimental Brain Tumors Mediated by Adenovirus, Herpes Simplex Virus, and Retrovirus Vectors. Human Gene Therapy. 5(2). 183–191. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026